267 related articles for article (PubMed ID: 22830600)
21. Rescue of HIV-1 long-time archived X4 strains to escape maraviroc.
Baatz F; Struck D; Lemaire M; De Landtsheer S; Servais JY; Arendt V; Schmit JC; Perez Bercoff D
Antiviral Res; 2011 Dec; 92(3):488-92. PubMed ID: 22020304
[TBL] [Abstract][Full Text] [Related]
22. An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.
Sterjovski J; Roche M; Churchill MJ; Ellett A; Farrugia W; Gray LR; Cowley D; Poumbourios P; Lee B; Wesselingh SL; Cunningham AL; Ramsland PA; Gorry PR
Virology; 2010 Sep; 404(2):269-78. PubMed ID: 20570309
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropism.
Roche M; Jakobsen MR; Sterjovski J; Ellett A; Posta F; Lee B; Jubb B; Westby M; Lewin SR; Ramsland PA; Churchill MJ; Gorry PR
J Virol; 2011 May; 85(9):4330-42. PubMed ID: 21345957
[TBL] [Abstract][Full Text] [Related]
24. Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.
Nedellec R; Coetzer M; Lederman MM; Offord RE; Hartley O; Mosier DE
PLoS One; 2011; 6(7):e22020. PubMed ID: 21760945
[TBL] [Abstract][Full Text] [Related]
25. Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach.
Sierra S; Kaiser R; Lübke N; Thielen A; Schuelter E; Heger E; Däumer M; Reuter S; Esser S; Fätkenheuer G; Pfister H; Oette M; Lengauer T
J Vis Exp; 2011 Dec; (58):. PubMed ID: 22157596
[TBL] [Abstract][Full Text] [Related]
26. A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5.
Tilton JC; Wilen CB; Didigu CA; Sinha R; Harrison JE; Agrawal-Gamse C; Henning EA; Bushman FD; Martin JN; Deeks SG; Doms RW
J Virol; 2010 Oct; 84(20):10863-76. PubMed ID: 20702642
[TBL] [Abstract][Full Text] [Related]
27. SCOTCH: subtype A coreceptor tropism classification in HIV-1.
Löchel HF; Riemenschneider M; Frishman D; Heider D
Bioinformatics; 2018 Aug; 34(15):2575-2580. PubMed ID: 29554213
[TBL] [Abstract][Full Text] [Related]
28. Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.
Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DF; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR
J Virol; 2009 Jun; 83(11):5430-41. PubMed ID: 19321618
[TBL] [Abstract][Full Text] [Related]
29. Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism.
Jeanne N; Saliou A; Carcenac R; Lefebvre C; Dubois M; Cazabat M; Nicot F; Loiseau C; Raymond S; Izopet J; Delobel P
Sci Rep; 2015 Nov; 5():16944. PubMed ID: 26585833
[TBL] [Abstract][Full Text] [Related]
30. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.
Tan Q; Zhu Y; Li J; Chen Z; Han GW; Kufareva I; Li T; Ma L; Fenalti G; Li J; Zhang W; Xie X; Yang H; Jiang H; Cherezov V; Liu H; Stevens RC; Zhao Q; Wu B
Science; 2013 Sep; 341(6152):1387-90. PubMed ID: 24030490
[TBL] [Abstract][Full Text] [Related]
31. A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.
Murray EJ; Leaman DP; Pawa N; Perkins H; Pickford C; Perros M; Zwick MB; Butler SL
J Virol; 2010 Jul; 84(14):7288-99. PubMed ID: 20427524
[TBL] [Abstract][Full Text] [Related]
32. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Sandres-Sauné K; Cuzin L; Marchou B; Massip P; Izopet J
AIDS; 2008 Sep; 22(14):F11-6. PubMed ID: 18753930
[TBL] [Abstract][Full Text] [Related]
33. Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.
Del Prete GQ; Leslie GJ; Haggarty B; Jordan AP; Romano J; Hoxie JA
J Virol; 2010 Sep; 84(17):8777-89. PubMed ID: 20573813
[TBL] [Abstract][Full Text] [Related]
34. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility of HIV type 2 primary isolates to CCR5 and CXCR4 monoclonal antibodies, ligands, and small molecule inhibitors.
Espirito-Santo M; Santos-Costa Q; Calado M; Dorr P; Azevedo-Pereira JM
AIDS Res Hum Retroviruses; 2012 May; 28(5):478-85. PubMed ID: 21902586
[TBL] [Abstract][Full Text] [Related]
36. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
Jensen MA; Li FS; van 't Wout AB; Nickle DC; Shriner D; He HX; McLaughlin S; Shankarappa R; Margolick JB; Mullins JI
J Virol; 2003 Dec; 77(24):13376-88. PubMed ID: 14645592
[TBL] [Abstract][Full Text] [Related]
37. Coreceptor Tropism and Maraviroc Sensitivity of Clonally Derived Ethiopian HIV-1C Strains Using an in-house Phenotypic Assay and Commonly Used Genotypic Methods.
Kalu AW; Telele NF; Aralaguppe SG; Gebre-Selassie S; Fekade D; Marrone G; Sonnerborg A
Curr HIV Res; 2018; 16(2):113-120. PubMed ID: 29766813
[TBL] [Abstract][Full Text] [Related]
38. Structure and dynamics of the gp120 V3 loop that confers noncompetitive resistance in R5 HIV-1(JR-FL) to maraviroc.
Yuan Y; Yokoyama M; Maeda Y; Terasawa H; Harada S; Sato H; Yusa K
PLoS One; 2013; 8(6):e65115. PubMed ID: 23840315
[TBL] [Abstract][Full Text] [Related]
39. Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.
Weber J; Vazquez AC; Winner D; Gibson RM; Rhea AM; Rose JD; Wylie D; Henry K; Wright A; King K; Archer J; Poveda E; Soriano V; Robertson DL; Olivo PD; Arts EJ; Quiñones-Mateu ME
J Clin Microbiol; 2013 May; 51(5):1517-27. PubMed ID: 23486708
[TBL] [Abstract][Full Text] [Related]
40. Critical amino acids within the human immunodeficiency virus type 1 envelope glycoprotein V4 N- and C-terminals contribute to virus entry.
Li Y; Yang D; Wang JY; Yao Y; Zhang WZ; Wang LJ; Cheng DC; Yang FK; Zhang FM; Zhuang M; Ling H
PLoS One; 2014; 9(1):e86083. PubMed ID: 24465884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
